These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26808357)

  • 1. Strategy for the Prediction of Steady-State Exposure of Digoxin to Determine Drug-Drug Interaction Potential of Digoxin With Other Drugs in Digitalization Therapy.
    Srinivas NR
    Am J Ther; 2019; 26(1):e54-e65. PubMed ID: 26808357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models.
    Srinivas NR; Syed M
    Drugs R D; 2016 Mar; 16(1):69-79. PubMed ID: 26747454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the Prediction of Area Under the Curve for a Protease Inhibitor Using Trough Versus Peak Concentration: Assessment Using Published Pharmacokinetic Data for Indinavir.
    Srinivas NR
    Am J Ther; 2017; 24(4):e405-e418. PubMed ID: 26291590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin.
    Kadokura T; Groenendaal D; Heeringa M; Mol R; Verheggen F; Garcia-Hernandez A; Onkels H
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):1-9. PubMed ID: 23754514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects.
    Chong E; Kalia V; Willsie S; Winkle P
    J Nephrol; 2014 Dec; 27(6):659-66. PubMed ID: 24699894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal Rivastigmine Delivery for Alzheimer Disease: Amenability of Exposure Predictions of Rivastigmine and Metabolite, NAP226-90, by Linear Regression Model Using Limited Samples.
    Srinivas NR
    Clin Neuropharmacol; 2016; 39(4):169-77. PubMed ID: 27332627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
    Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
    J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morning-evening administration time differences in digoxin kinetics in healthy young subjects.
    Erol K; Kiliç FS; Batu OS; Yildirim E
    Chronobiol Int; 2001 Sep; 18(5):841-9. PubMed ID: 11763991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of captopril on serum digoxin levels in patients with severe congestive heart failure.
    Kirimli O; Kalkan S; Guneri S; Tuncok Y; Akdeniz B; Ozdamar M; Guven H
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):311-4. PubMed ID: 11471775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
    Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
    Srinivas NR
    Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.
    Srinivas NR; Syed M
    J Pain Palliat Care Pharmacother; 2016; 30(1):13-24. PubMed ID: 26865407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of troglitazone on steady-state pharmacokinetics of digoxin.
    Loi CM; Knowlton PW; Stern R; Randinitis EJ; Vassos AB; Koup JR; Sedman AJ
    J Clin Pharmacol; 1998 Feb; 38(2):178-83. PubMed ID: 9549650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole does not affect the steady-state pharmacokinetics of digoxin.
    Purkins L; Wood N; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):45-50. PubMed ID: 14616413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Drug Interactions of the Nonsteroidal Mineralocorticoid Receptor Antagonist Apararenone With Midazolam, Warfarin, and Digoxin: A Phase 1 Studies in Healthy Volunteers.
    Nakamura T; Shimizu H; Kawaguchi A
    Clin Ther; 2020 Nov; 42(11):2171-2183.e4. PubMed ID: 33153727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of digoxin dry elixir as a novel dosage form using a spray-drying technique.
    Kim CK; Yoon YS
    J Microencapsul; 1995; 12(5):547-56. PubMed ID: 8544098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
    Devineni D; Manitpisitkul P; Vaccaro N; Bernard A; Skee D; Mamidi RN; Tian H; Weiner S; Stieltjes H; Sha S; Rothenberg P
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):41-53. PubMed ID: 25345427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can available mathematical models predict serum digoxin levels in Thai patients?
    Jiratham-Opas J; Kanjanavanit R; Wongcharoen W; Punyawudho B; Arunmanakul P; Amaritakomol A; Topaiboon P; Gunaparn S; Phrommintikul A
    J Clin Pharm Ther; 2018 Jun; 43(3):377-384. PubMed ID: 29365353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Sampling Strategy for Accurate Prediction of Pharmacokinetics of Saroglitazar: A 3-point Linear Regression Model Development and Successful Prediction of Human Exposure.
    Joshi SN; Srinivas NR; Parmar DV
    Clin Ther; 2018 Mar; 40(3):456-468.e1. PubMed ID: 29496320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.